Enteral Medical Nutrition Market
Enteral Medical Nutrition Market Analysis, By Indication (Respiratory Disorders, Cancer, Liver Failure, Others), By Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, Others), By Nutrition Type (Supplemental and Sole-Source), By Distribution Channel, Form & Region – Global Market Insight 2022-2032
Analysis of Enteral Medical Nutrition Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Enteral Medical Nutrition Market Outlook (2022-2032)
The enteral medical nutrition market is likely to expand its roots at a CAGR of 5.8% during the forecast period of 2022-2032. The market holds a value of 8,256.05 million in 2022, while it is anticipated to cross a revenue of US$ 14,508 million by 2032.
Enteral medical nutrition involves feeding through the gastrointestinal tract to provide calories and nutrition. The form of nutrition is delivered as a liquid through tube feeding or directly consuming it. Numerous nutrition beverages and formulas help patients with different deficiencies get enough nutrients.
Patients suffering from various chronic diseases and poor appetites are unable to eat enough food and require additional nutrients, expanding the enteral medical nutrition market size. Enteral medical nutrition beverages help patients that suffer from illnesses and can’t consume nutritional food. Thus, government programs and medical workshops help in spreading awareness about the application of NG tubes for nutritional delivery.
Healthcare facilities demand tools that can easily deliver nutrients to the patient going through treatment or are on a ventilator. Early nutritional support in the form of enteral nutrition delivers important benefits in terms of the interaction between the gut and systemic immune response in chronically ill patients. The outcome of its applications helps in maintaining gut integrity and physiologic stress response, increasing its adoption in healthcare services.
Crohn’s disease is a complex chronic disorder that majorly affects the digestive system. More than half a million North American and Western European citizens suffer from the disease. Enteral medical nutrition is delivered through the tube-feeding process.
The rising cases of gastrointestinal disease due to nutritional deterioration is common among US citizens. The diagnostic tests, appetite loss, and therapeutic dietary restriction fuel the demand for enteral medical nutrition.
Rising cases of strokes, cancer, and critical illness or injuries trigger the impairment of swallowing capability along with fatigue, nausea, and vomiting. Therefore, enteral medical nutrition.
Report Attributes |
Details |
|
Market Size (2022) |
USD 8,256.05 Million |
|
Projected Market Value (2032) |
USD 14,508 Million |
|
Global Market Growth Rate |
5.8% |
|
Cancer Indication Segment Market CAGR |
7.4% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Various feeding solutions for the enteral medical nutrition delivery
The diversification of the enteral medical nutrition system involves six different types of enteral nutrition feeding practices. These tubes involve further subtypes depending on exactly where they end the stomach or intestines. Medical healthcare services adopt the enteral nutrition systems that enter through the different entrances. Thus, vendors adopt these different delivery tools.
Nasogastric Tube (NGT) :-
While the nasogastric tube is a thin and flexible tube that is inserted inside the nose while it travels down the esophagus into the stomach to carry nutritional food items in the form of liquid, it can be used for all feedings or for giving a person extra calories. The facilities that deal with chronic patients along with the patients having to sever injuries.
Orogastric Tube (OGT) :-
The only difference between OG and NG tubes is the OG tube is inserted from the mouth as it enters the stomach. This is considered the best for patients suffering from injuries in the nose or the windpipe is blocked. These tubes also help in removing the air from the baby’s stomach.
Boasting cases of Cachexia fuels the demand for the Enteral
Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. The condition occurs in patients that suffer from chronic kidney and heart diseases. While cancer cachexia negatively impacts the quality of life. This involves trouble in eating and consuming any food item. Therefore, the rising cases of cachexia are driving the higher adoption of enteral medical nutrition delivery systems.
WHO recorded 10 million deaths and 15.6 million new cases of cancer in 2020. Thus, people with severe ere symptoms require additional food nutrients support that is provided through the enteral medical nutrition supply.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Segmentation Insights
What Indication Type Accounts for Most Revenue Generation in the Enteral Medical Nutrition Market?
The respiratory disorders segment tops the indication category with a CAGR of 7.4% during the forecast period. The factors driving the growth of this segment are the increasing population leading people to get more respiratory diseases. Respiratory diseases lead to the lack of oxygen reaching the mind, which further affects functioning and ends up as a stroke.
Therefore, patients adopting enteral medical nutrition solutions are majorly suffering from respiratory illness. Abbott has recently introduced its supplement named pulmonary, which carries high-calorie, modified carbohydrates for patients suffering from COPD and respiratory failure. Other than this, the respiratory segment is further divided into chronic obtrusive pulmonary disease (COPD), respiratory failure, cystic fibrosis, and others.
Why is Supplement Segment a leading Nutrition Type Segment in Enteral medical nutrition Industry?
The supplemental segment will hold a larger market share in 2022, while the sole-source segment is anticipated to register a higher CAGR during the forecast period. The patients that receive the supplemental source of nutrition are subjected to stay within the hospital for a prolonged period.
Healthcare facilities are focusing on adopting nutrition that helps a larger set of patients that have different indications but a common nutritional requirement. These are the nutritional formulas that are rich in Omega-3, glutamine, ribonucleic acids, and fatty acids. These elements help the patient in the fulfillment of their diet while also healing their body at a slow rate.
Which Product type is Poised to Drive Enteral Medical Nutrition Market
The standard protein diet segment held the largest share of the market in 2022. However, the fruit juice-based oral nutrient segment is anticipated to register the highest CAGR during the forecast period. Other segments involve standard protein diet, high protein diet, fruit juice-based oral nutrients, etc.
Country Insights
How Will the U.S. Enteral Medical Nutrition Market Evolve?
The US government is launching multiple initiatives to boost the market. For example, the Feeding Tube Awareness Foundation is creating awareness about feeding tube adoption. This also integrates with the natal care movement running across the country as the tube-feeding becomes a part of natal care in cases of complications.
North America dominated the enteral medical nutrition market in 2021. Therefore, the increasing number of US FDA approvals for enteral nutrition products would drive the market growth during the forecast period (2022-2032)
Lucrative growth in Asia Pacific region is led by the Geriatric Population Rise
Asia-Pacific has become a lucrative space for opportunities involving key players operating in the enteral nutrition market, attributing to an increase in the patient population suffering from diseases such as cancer, neurological disorders, gastrointestinal disorders, diabetes, and other chronic conditions.
The Asia-pacific region has a huge population that lies between the age of 12-30. The new geriatric population has a low immune system and even lower nutrition quotient. Therefore, the increase in the geriatric population in emerging economies, the development of the R&D sector,
Why is China's Enteral medical nutrition Market Growing the Fastest Among Major Economies?
Growth is expected to be driven by rising demand for diagnostic products, as well as rising healthcare expenditures, over the forecast period. The growing geriatric population, rising chronic disease incidences, and increased development of advanced products are expected to drive market growth.
The Japanese Market to Expand Rapidly in the Coming Years
The Enteral medical nutrition industry growth is being driven by on-going medical infrastructure expansion as well as increased government and private sector investments to promote the use of safer and more cost-effective healthcare solutions.
Comparative View of Adjacent Enteral medical nutrition Industry
Enteral Medical Nutrition Industry:
|
Attributes |
Enteral Medical Nutrition Market |
|
CAGR (2022-2032) |
5.8% |
|
Market Value (2027) |
US$ 10.94 Bn |
|
Growth Factor |
Rising cases of cancer followed by advent of covid-19 and rise of respiratory diseases have led the healthcare services adopt the enteral medical nutrition as supplements and beverage supply. |
|
Opportunity |
The advanced nutritional supply targets patients with special diseases and largely provides support to the digestive system with higher proteins, acids, and other fluids. |
|
Key Trends |
The enteral medical nutrition supplies coming with caloric densities of 1.0, 1.2, 1.5 are the latest addition that trends among the vendors. |
Skin Cancer Diagnostics & Therapeutics Market :
|
Attributes |
Skin Cancer Diagnostics & Therapeutics Market |
|
CAGR (2022-2032) |
10% |
|
Market Value (2027) |
US$ 11.6 Bn |
|
Growth Factor |
Pollution and direct exposition to the UV rays is leading to the rising number of skin cancer patients in the various parts of the countries, pushing the skin cancer diagnostics & therapeutics market upward. |
|
Opportunity |
New advanced versions and stages are a challenge that creates multiple opportunities for the skin cancer diagnostics & therapeutics market to experiment and diversify their approach. |
|
Key Trends |
To get into multiple layers of symptoms, followed by the first line protocol while integrating with Artificial intelligence and machine learning. |
Oncology Market :
|
Attributes |
Oncology Market |
|
CAGR (2022-2032) |
8% |
|
Market Value (2027) |
US$ 378 Bn |
|
Growth Factor |
Rising awareness regarding cancer and availability of various oncology treatments and innovative diagnostic tools, fueling the demand for oncology analysts. |
|
Opportunity |
The market creates opportunities for the component markets like cancer diagnosis and therapeutic, helping them find their space in the market race. |
|
Key Trends |
The machine learning and internet of things (IOT) integrate with oncology tools to make it easy and accurate are flourishing the trends of oncology market. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitors Landscape
Competitors in enteral medical nutrition market are focusing on providing the wholesome liquid supply that involves all the nutrients such as fatty acids, and ribonucleic acids. To further strengthen their position in the market, the market players are implementing a variety of strategies, including mergers and acquisitions, partnerships, innovations, and product launches, such as the launch of osmometer products.
The enteral medical nutrition market is extremely fragmented, with many of the players being local or regional. Players in the market are concentrating on launching cutting-edge products and expanding geographically.
Recent Development :
|
Date |
Company Name |
Strategy |
Details |
|
June 2022 |
Abott |
Introduction |
Abbott Healthcare has introduced a long range of medical nutrition supplies for all the ages ranging from kids to elder people. The range of products involve Ensure (Provides strength and energy to the patient), Elecare (Amino Acid-based formula), Glucerna (Delicious meal or snack replacement). Abbott has recently introduced its supplement named pulmore which carries high-calorie, modified carbohydrates for patients suffering from COPD, and respiratory failure. |
|
September 2021 |
Fresenius-Kabi |
Introduction |
Fresenius-Kabi have reshaped and revisited its long range of ENLocks, feeding pumps, giving sets along with the enteral medical nutrition supply such as kkabimmune, kabisure, fresubin DM. |
|
September, 2022 |
Nestle Health Science |
Acquisition |
Nestlé Health Science acquired Puravida, a premium Brazilian nutrition and health lifestyle brand. The acquisition will enable NHSc to expand its consumer health portfolio in Brazil. Puravida's mix of products complements Nestlé Health Science’s portfolio, which already has an offering in oral nutritional supplements, protein powders, and ready-to-drink nutritional beverages in Brazil. |
|
August 2019 |
Smartfish AS |
Collaboration |
Smartfish AS has followed a strategic collaboration with an international healthcare brand B. Braun to secure a global launch of its medical nutrition product Remune. B. Braun have launched Remune in close to 20 countries during 2019–2020, followed by several other markets in Europe, Asia, and South America. The collaboration also generates traction for other potential launches by B. Braun of other innovative products based on Smartfish’s technology. |
Key Segments
-
By Indication :
- Respiratory Disorders
- Cancer
- Post COVID-19
- Gastrointestinal Disorders
- Liver Failure
-
By Nutrition Type :
- Supplemental and
- Sole-Source
-
By Form :
- Powder
- Liquid
- Semi-Solid)
-
By Product :
- Standard Protein Diet
- High Protein Diet
- Fruit Juice Based Oral Nutritional Supplement
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Stores
-
By Age Group :
- Child (Till 18 Years)
- Adults (18+years)
-
By Region :
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032 5.3.1. Respiratory Disorders 5.3.1.1. Chronic Obstructive Pulmonary Disease 5.3.1.2. Respiratory Failure 5.3.1.3. Cystic Fibrosis 5.3.1.4. Others 5.3.2. Cancer 5.3.2.1. Cancer Cachexia 5.3.2.2. Cachexia With COPD 5.3.2.3. Others 5.3.3. Gastrointestinal Disorders 5.3.3.1. Bowel Obstruction 5.3.3.2. Crohn's Disease 5.3.3.3. Short Bowel Syndrome 5.3.3.4. Others 5.3.4. Liver Failure 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021 5.5. Absolute $ Opportunity Analysis By Indication, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Nutrition Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Nutrition Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Nutrition Type, 2022-2032 6.3.1. Supplemental 6.3.2. Sole-Source 6.4. Y-o-Y Growth Trend Analysis By Nutrition Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Nutrition Type, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Form 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Form , 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Form , 2022-2032 7.3.1. Powder 7.3.2. Liquid 7.3.3. Semi-Solid 7.4. Y-o-Y Growth Trend Analysis By Form , 2017-2021 7.5. Absolute $ Opportunity Analysis By Form , 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032 8.3.1. Standard Protein Diet 8.3.2. High Protein Diet 8.3.3. Others 8.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021 8.5. Absolute $ Opportunity Analysis By Product, 2022-2032 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021 9.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032 9.3.1. Hospital Pharmacies 9.3.2. Retail Pharmacies 9.3.3. Others 9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Age Group 10.1. Introduction / Key Findings 10.2. Historical Market Size Value (US$ Mn) Analysis By Age Group, 2017-2021 10.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group, 2022-2032 10.3.1. Child - Till 18 Years 10.3.2. Adult - Above 18 Years 10.4. Y-o-Y Growth Trend Analysis By Age Group, 2017-2021 10.5. Absolute $ Opportunity Analysis By Age Group, 2022-2032 11. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 11.1. Introduction 11.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 11.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. MEA 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. U.S. 12.2.1.2. Canada 12.2.2. By Indication 12.2.3. By Nutrition Type 12.2.4. By Form 12.2.5. By Product 12.2.6. By Distribution Channel 12.2.7. By Age Group 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By Nutrition Type 12.3.4. By Form 12.3.5. By Product 12.3.6. By Distribution Channel 12.3.7. By Age Group 12.4. Key Takeaways 13. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. Brazil 13.2.1.2. Mexico 13.2.1.3. Rest of Latin America 13.2.2. By Indication 13.2.3. By Nutrition Type 13.2.4. By Form 13.2.5. By Product 13.2.6. By Distribution Channel 13.2.7. By Age Group 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Indication 13.3.3. By Nutrition Type 13.3.4. By Form 13.3.5. By Product 13.3.6. By Distribution Channel 13.3.7. By Age Group 13.4. Key Takeaways 14. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. Germany 14.2.1.2. U.K. 14.2.1.3. France 14.2.1.4. Spain 14.2.1.5. Italy 14.2.1.6. Rest of Europe 14.2.2. By Indication 14.2.3. By Nutrition Type 14.2.4. By Form 14.2.5. By Product 14.2.6. By Distribution Channel 14.2.7. By Age Group 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Indication 14.3.3. By Nutrition Type 14.3.4. By Form 14.3.5. By Product 14.3.6. By Distribution Channel 14.3.7. By Age Group 14.4. Key Takeaways 15. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.1.4. Singapore 15.2.1.5. Thailand 15.2.1.6. Indonesia 15.2.1.7. Australia 15.2.1.8. New Zealand 15.2.1.9. Rest of Asia Pacific 15.2.2. By Indication 15.2.3. By Nutrition Type 15.2.4. By Form 15.2.5. By Product 15.2.6. By Distribution Channel 15.2.7. By Age Group 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Indication 15.3.3. By Nutrition Type 15.3.4. By Form 15.3.5. By Product 15.3.6. By Distribution Channel 15.3.7. By Age Group 15.4. Key Takeaways 16. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Indication 16.2.3. By Nutrition Type 16.2.4. By Form 16.2.5. By Product 16.2.6. By Distribution Channel 16.2.7. By Age Group 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Indication 16.3.3. By Nutrition Type 16.3.4. By Form 16.3.5. By Product 16.3.6. By Distribution Channel 16.3.7. By Age Group 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. U.S. 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2021 17.1.2.1. By Indication 17.1.2.2. By Nutrition Type 17.1.2.3. By Form 17.1.2.4. By Product 17.1.2.5. By Distribution Channel 17.1.2.6. By Age Group 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2021 17.2.2.1. By Indication 17.2.2.2. By Nutrition Type 17.2.2.3. By Form 17.2.2.4. By Product 17.2.2.5. By Distribution Channel 17.2.2.6. By Age Group 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2021 17.3.2.1. By Indication 17.3.2.2. By Nutrition Type 17.3.2.3. By Form 17.3.2.4. By Product 17.3.2.5. By Distribution Channel 17.3.2.6. By Age Group 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2021 17.4.2.1. By Indication 17.4.2.2. By Nutrition Type 17.4.2.3. By Form 17.4.2.4. By Product 17.4.2.5. By Distribution Channel 17.4.2.6. By Age Group 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2021 17.5.2.1. By Indication 17.5.2.2. By Nutrition Type 17.5.2.3. By Form 17.5.2.4. By Product 17.5.2.5. By Distribution Channel 17.5.2.6. By Age Group 17.6. U.K. 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2021 17.6.2.1. By Indication 17.6.2.2. By Nutrition Type 17.6.2.3. By Form 17.6.2.4. By Product 17.6.2.5. By Distribution Channel 17.6.2.6. By Age Group 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2021 17.7.2.1. By Indication 17.7.2.2. By Nutrition Type 17.7.2.3. By Form 17.7.2.4. By Product 17.7.2.5. By Distribution Channel 17.7.2.6. By Age Group 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2021 17.8.2.1. By Indication 17.8.2.2. By Nutrition Type 17.8.2.3. By Form 17.8.2.4. By Product 17.8.2.5. By Distribution Channel 17.8.2.6. By Age Group 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2021 17.9.2.1. By Indication 17.9.2.2. By Nutrition Type 17.9.2.3. By Form 17.9.2.4. By Product 17.9.2.5. By Distribution Channel 17.9.2.6. By Age Group 17.10. China 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2021 17.10.2.1. By Indication 17.10.2.2. By Nutrition Type 17.10.2.3. By Form 17.10.2.4. By Product 17.10.2.5. By Distribution Channel 17.10.2.6. By Age Group 17.11. Japan 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2021 17.11.2.1. By Indication 17.11.2.2. By Nutrition Type 17.11.2.3. By Form 17.11.2.4. By Product 17.11.2.5. By Distribution Channel 17.11.2.6. By Age Group 17.12. South Korea 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2021 17.12.2.1. By Indication 17.12.2.2. By Nutrition Type 17.12.2.3. By Form 17.12.2.4. By Product 17.12.2.5. By Distribution Channel 17.12.2.6. By Age Group 17.13. Singapore 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2021 17.13.2.1. By Indication 17.13.2.2. By Nutrition Type 17.13.2.3. By Form 17.13.2.4. By Product 17.13.2.5. By Distribution Channel 17.13.2.6. By Age Group 17.14. Thailand 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2021 17.14.2.1. By Indication 17.14.2.2. By Nutrition Type 17.14.2.3. By Form 17.14.2.4. By Product 17.14.2.5. By Distribution Channel 17.14.2.6. By Age Group 17.15. Indonesia 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2021 17.15.2.1. By Indication 17.15.2.2. By Nutrition Type 17.15.2.3. By Form 17.15.2.4. By Product 17.15.2.5. By Distribution Channel 17.15.2.6. By Age Group 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2021 17.16.2.1. By Indication 17.16.2.2. By Nutrition Type 17.16.2.3. By Form 17.16.2.4. By Product 17.16.2.5. By Distribution Channel 17.16.2.6. By Age Group 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2021 17.17.2.1. By Indication 17.17.2.2. By Nutrition Type 17.17.2.3. By Form 17.17.2.4. By Product 17.17.2.5. By Distribution Channel 17.17.2.6. By Age Group 17.18. GCC Countries 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2021 17.18.2.1. By Indication 17.18.2.2. By Nutrition Type 17.18.2.3. By Form 17.18.2.4. By Product 17.18.2.5. By Distribution Channel 17.18.2.6. By Age Group 17.19. South Africa 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2021 17.19.2.1. By Indication 17.19.2.2. By Nutrition Type 17.19.2.3. By Form 17.19.2.4. By Product 17.19.2.5. By Distribution Channel 17.19.2.6. By Age Group 17.20. Israel 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2021 17.20.2.1. By Indication 17.20.2.2. By Nutrition Type 17.20.2.3. By Form 17.20.2.4. By Product 17.20.2.5. By Distribution Channel 17.20.2.6. By Age Group 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Indication 18.3.3. By Nutrition Type 18.3.4. By Form 18.3.5. By Product 18.3.6. By Distribution Channel 18.3.7. By Age Group 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Abbott Laboratories 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Nutricia 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Fresenius Kabi AG 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. B. Braun Melsungen AG 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Nestlé 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Meiji Holdings Co., Ltd. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Smart Fish AS 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. DSM Nutritional Products AG 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Hormel Foods Corporation 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Global Health Products Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 03: Global Market Value (US$ Mn) Forecast by Nutrition Type, 2017-2032
Table 04: Global Market Value (US$ Mn) Forecast by Form , 2017-2032
Table 05: Global Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 06: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 07: Global Market Value (US$ Mn) Forecast by Age Group, 2017-2032
Table 08: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 09: North America Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 10: North America Market Value (US$ Mn) Forecast by Nutrition Type, 2017-2032
Table 11: North America Market Value (US$ Mn) Forecast by Form , 2017-2032
Table 12: North America Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 13: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 14: North America Market Value (US$ Mn) Forecast by Age Group, 2017-2032
Table 15: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 16: Latin America Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 17: Latin America Market Value (US$ Mn) Forecast by Nutrition Type, 2017-2032
Table 18: Latin America Market Value (US$ Mn) Forecast by Form , 2017-2032
Table 19: Latin America Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 20: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 21: Latin America Market Value (US$ Mn) Forecast by Age Group, 2017-2032
Table 22: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 23: Europe Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 24: Europe Market Value (US$ Mn) Forecast by Nutrition Type, 2017-2032
Table 25: Europe Market Value (US$ Mn) Forecast by Form , 2017-2032
Table 26: Europe Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 27: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 28: Europe Market Value (US$ Mn) Forecast by Age Group, 2017-2032
Table 29: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 30: Asia Pacific Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 31: Asia Pacific Market Value (US$ Mn) Forecast by Nutrition Type, 2017-2032
Table 32: Asia Pacific Market Value (US$ Mn) Forecast by Form , 2017-2032
Table 33: Asia Pacific Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 34: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 35: Asia Pacific Market Value (US$ Mn) Forecast by Age Group, 2017-2032
Table 36: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 37: MEA Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 38: MEA Market Value (US$ Mn) Forecast by Nutrition Type, 2017-2032
Table 39: MEA Market Value (US$ Mn) Forecast by Form , 2017-2032
Table 40: MEA Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 41: MEA Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 42: MEA Market Value (US$ Mn) Forecast by Age Group, 2017-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Indication, 2022-2032
Figure 02: Global Market Value (US$ Mn) by Nutrition Type, 2022-2032
Figure 03: Global Market Value (US$ Mn) by Form , 2022-2032
Figure 04: Global Market Value (US$ Mn) by Product, 2022-2032
Figure 05: Global Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 06: Global Market Value (US$ Mn) by Age Group, 2022-2032
Figure 07: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 08: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 09: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 11: Global Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 14: Global Market Value (US$ Mn) Analysis by Nutrition Type, 2017-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by Nutrition Type, 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by Nutrition Type, 2022-2032
Figure 17: Global Market Value (US$ Mn) Analysis by Form , 2017-2032
Figure 18: Global Market Value Share (%) and BPS Analysis by Form , 2022-2032
Figure 19: Global Market Y-o-Y Growth (%) Projections by Form , 2022-2032
Figure 20: Global Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 21: Global Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 22: Global Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 23: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 24: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 25: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 26: Global Market Value (US$ Mn) Analysis by Age Group, 2017-2032
Figure 27: Global Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 28: Global Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 29: Global Market Attractiveness by Indication, 2022-2032
Figure 30: Global Market Attractiveness by Nutrition Type, 2022-2032
Figure 31: Global Market Attractiveness by Form , 2022-2032
Figure 32: Global Market Attractiveness by Product, 2022-2032
Figure 33: Global Market Attractiveness by Distribution Channel, 2022-2032
Figure 34: Global Market Attractiveness by Age Group, 2022-2032
Figure 35: Global Market Attractiveness by Region, 2022-2032
Figure 36: North America Market Value (US$ Mn) by Indication, 2022-2032
Figure 37: North America Market Value (US$ Mn) by Nutrition Type, 2022-2032
Figure 38: North America Market Value (US$ Mn) by Form , 2022-2032
Figure 39: North America Market Value (US$ Mn) by Product, 2022-2032
Figure 40: North America Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 41: North America Market Value (US$ Mn) by Age Group, 2022-2032
Figure 42: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 43: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 46: North America Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 47: North America Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 48: North America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 49: North America Market Value (US$ Mn) Analysis by Nutrition Type, 2017-2032
Figure 50: North America Market Value Share (%) and BPS Analysis by Nutrition Type, 2022-2032
Figure 51: North America Market Y-o-Y Growth (%) Projections by Nutrition Type, 2022-2032
Figure 52: North America Market Value (US$ Mn) Analysis by Form , 2017-2032
Figure 53: North America Market Value Share (%) and BPS Analysis by Form , 2022-2032
Figure 54: North America Market Y-o-Y Growth (%) Projections by Form , 2022-2032
Figure 55: North America Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 56: North America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 57: North America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 58: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 59: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 60: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 61: North America Market Value (US$ Mn) Analysis by Age Group, 2017-2032
Figure 62: North America Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 63: North America Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 64: North America Market Attractiveness by Indication, 2022-2032
Figure 65: North America Market Attractiveness by Nutrition Type, 2022-2032
Figure 66: North America Market Attractiveness by Form , 2022-2032
Figure 67: North America Market Attractiveness by Product, 2022-2032
Figure 68: North America Market Attractiveness by Distribution Channel, 2022-2032
Figure 69: North America Market Attractiveness by Age Group, 2022-2032
Figure 70: North America Market Attractiveness by Country, 2022-2032
Figure 71: Latin America Market Value (US$ Mn) by Indication, 2022-2032
Figure 72: Latin America Market Value (US$ Mn) by Nutrition Type, 2022-2032
Figure 73: Latin America Market Value (US$ Mn) by Form , 2022-2032
Figure 74: Latin America Market Value (US$ Mn) by Product, 2022-2032
Figure 75: Latin America Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 76: Latin America Market Value (US$ Mn) by Age Group, 2022-2032
Figure 77: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 78: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 79: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 80: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 81: Latin America Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 82: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 83: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 84: Latin America Market Value (US$ Mn) Analysis by Nutrition Type, 2017-2032
Figure 85: Latin America Market Value Share (%) and BPS Analysis by Nutrition Type, 2022-2032
Figure 86: Latin America Market Y-o-Y Growth (%) Projections by Nutrition Type, 2022-2032
Figure 87: Latin America Market Value (US$ Mn) Analysis by Form , 2017-2032
Figure 88: Latin America Market Value Share (%) and BPS Analysis by Form , 2022-2032
Figure 89: Latin America Market Y-o-Y Growth (%) Projections by Form , 2022-2032
Figure 90: Latin America Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 91: Latin America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 92: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 93: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 94: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 95: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 96: Latin America Market Value (US$ Mn) Analysis by Age Group, 2017-2032
Figure 97: Latin America Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 98: Latin America Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 99: Latin America Market Attractiveness by Indication, 2022-2032
Figure 100: Latin America Market Attractiveness by Nutrition Type, 2022-2032
Figure 101: Latin America Market Attractiveness by Form , 2022-2032
Figure 102: Latin America Market Attractiveness by Product, 2022-2032
Figure 103: Latin America Market Attractiveness by Distribution Channel, 2022-2032
Figure 104: Latin America Market Attractiveness by Age Group, 2022-2032
Figure 105: Latin America Market Attractiveness by Country, 2022-2032
Figure 106: Europe Market Value (US$ Mn) by Indication, 2022-2032
Figure 107: Europe Market Value (US$ Mn) by Nutrition Type, 2022-2032
Figure 108: Europe Market Value (US$ Mn) by Form , 2022-2032
Figure 109: Europe Market Value (US$ Mn) by Product, 2022-2032
Figure 110: Europe Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 111: Europe Market Value (US$ Mn) by Age Group, 2022-2032
Figure 112: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 113: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 114: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 115: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 116: Europe Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 117: Europe Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 118: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 119: Europe Market Value (US$ Mn) Analysis by Nutrition Type, 2017-2032
Figure 120: Europe Market Value Share (%) and BPS Analysis by Nutrition Type, 2022-2032
Figure 121: Europe Market Y-o-Y Growth (%) Projections by Nutrition Type, 2022-2032
Figure 122: Europe Market Value (US$ Mn) Analysis by Form , 2017-2032
Figure 123: Europe Market Value Share (%) and BPS Analysis by Form , 2022-2032
Figure 124: Europe Market Y-o-Y Growth (%) Projections by Form , 2022-2032
Figure 125: Europe Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 126: Europe Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 127: Europe Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 128: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 129: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 130: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 131: Europe Market Value (US$ Mn) Analysis by Age Group, 2017-2032
Figure 132: Europe Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 133: Europe Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 134: Europe Market Attractiveness by Indication, 2022-2032
Figure 135: Europe Market Attractiveness by Nutrition Type, 2022-2032
Figure 136: Europe Market Attractiveness by Form , 2022-2032
Figure 137: Europe Market Attractiveness by Product, 2022-2032
Figure 138: Europe Market Attractiveness by Distribution Channel, 2022-2032
Figure 139: Europe Market Attractiveness by Age Group, 2022-2032
Figure 140: Europe Market Attractiveness by Country, 2022-2032
Figure 141: Asia Pacific Market Value (US$ Mn) by Indication, 2022-2032
Figure 142: Asia Pacific Market Value (US$ Mn) by Nutrition Type, 2022-2032
Figure 143: Asia Pacific Market Value (US$ Mn) by Form , 2022-2032
Figure 144: Asia Pacific Market Value (US$ Mn) by Product, 2022-2032
Figure 145: Asia Pacific Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 146: Asia Pacific Market Value (US$ Mn) by Age Group, 2022-2032
Figure 147: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 148: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 149: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 150: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 151: Asia Pacific Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 152: Asia Pacific Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 153: Asia Pacific Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 154: Asia Pacific Market Value (US$ Mn) Analysis by Nutrition Type, 2017-2032
Figure 155: Asia Pacific Market Value Share (%) and BPS Analysis by Nutrition Type, 2022-2032
Figure 156: Asia Pacific Market Y-o-Y Growth (%) Projections by Nutrition Type, 2022-2032
Figure 157: Asia Pacific Market Value (US$ Mn) Analysis by Form , 2017-2032
Figure 158: Asia Pacific Market Value Share (%) and BPS Analysis by Form , 2022-2032
Figure 159: Asia Pacific Market Y-o-Y Growth (%) Projections by Form , 2022-2032
Figure 160: Asia Pacific Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 161: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 162: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 163: Asia Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 164: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 165: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 166: Asia Pacific Market Value (US$ Mn) Analysis by Age Group, 2017-2032
Figure 167: Asia Pacific Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 168: Asia Pacific Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 169: Asia Pacific Market Attractiveness by Indication, 2022-2032
Figure 170: Asia Pacific Market Attractiveness by Nutrition Type, 2022-2032
Figure 171: Asia Pacific Market Attractiveness by Form , 2022-2032
Figure 172: Asia Pacific Market Attractiveness by Product, 2022-2032
Figure 173: Asia Pacific Market Attractiveness by Distribution Channel, 2022-2032
Figure 174: Asia Pacific Market Attractiveness by Age Group, 2022-2032
Figure 175: Asia Pacific Market Attractiveness by Country, 2022-2032
Figure 176: MEA Market Value (US$ Mn) by Indication, 2022-2032
Figure 177: MEA Market Value (US$ Mn) by Nutrition Type, 2022-2032
Figure 178: MEA Market Value (US$ Mn) by Form , 2022-2032
Figure 179: MEA Market Value (US$ Mn) by Product, 2022-2032
Figure 180: MEA Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 181: MEA Market Value (US$ Mn) by Age Group, 2022-2032
Figure 182: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 183: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 184: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 185: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 186: MEA Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 187: MEA Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 188: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 189: MEA Market Value (US$ Mn) Analysis by Nutrition Type, 2017-2032
Figure 190: MEA Market Value Share (%) and BPS Analysis by Nutrition Type, 2022-2032
Figure 191: MEA Market Y-o-Y Growth (%) Projections by Nutrition Type, 2022-2032
Figure 192: MEA Market Value (US$ Mn) Analysis by Form , 2017-2032
Figure 193: MEA Market Value Share (%) and BPS Analysis by Form , 2022-2032
Figure 194: MEA Market Y-o-Y Growth (%) Projections by Form , 2022-2032
Figure 195: MEA Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 196: MEA Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 197: MEA Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 198: MEA Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 199: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 200: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 201: MEA Market Value (US$ Mn) Analysis by Age Group, 2017-2032
Figure 202: MEA Market Value Share (%) and BPS Analysis by Age Group, 2022-2032
Figure 203: MEA Market Y-o-Y Growth (%) Projections by Age Group, 2022-2032
Figure 204: MEA Market Attractiveness by Indication, 2022-2032
Figure 205: MEA Market Attractiveness by Nutrition Type, 2022-2032
Figure 206: MEA Market Attractiveness by Form , 2022-2032
Figure 207: MEA Market Attractiveness by Product, 2022-2032
Figure 208: MEA Market Attractiveness by Distribution Channel, 2022-2032
Figure 209: MEA Market Attractiveness by Age Group, 2022-2032
Figure 210: MEA Market Attractiveness by Country, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the Current Enteral Medical Nutrition Market Size?
The enteral medical nutrition market holds a value of US$ 8,2656.05 million in 2022.
What is the Future Scope of Growth for the Enteral Medical Nutrition Market?
The enteral medical nutrition market is expected to surpass USD 14508 million by 2032.
How is the Enteral Medical Nutrition Market Growing?
The enteral medical nutrition market is predicted to grow at CAGR of 5.8% through 2032.
Which Region Holds the Highest Revenue Potential in the Enteral Medical Nutrition Market?
North America enteral medical nutrition market holds the highest revenue potential.
Enteral Medical Nutrition Market